French drugmaker Sanofi (Euronext: SAN) has placed a strong emphasis on the adoption of artificial intelligence capabilities to facilitate its internal operations.
The company is rolling out “plai,” a tool for Sanofi staff developed with AI platform company Aily Labs.
The app is designed to deliver “real-time, reactive data interactions,” Sanofi said, providing its employees with a comprehensive view of the company’s activities.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze